6018092266769/9/2024 9:49:58 AM9/9/2024 9:49:58 AMin Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma proven diagnosis of pleural mesothelioma with known histology (epithelioid vs STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx110https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{BA515E53-E50E-48C6-9B14-976E3B2B7036}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
6020373200419/9/2024 9:47:45 AM9/9/2024 9:47:45 AMPhase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of tumor diseases, including CRC, NSCLC, mesothelioma, pancreatic cancer, GC, head and STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx510https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{2C58A429-6F70-422C-80D8-C1C4B8252879}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
6021125458849/9/2024 9:44:26 AM9/9/2024 9:44:26 AMSurgery for Mesothelioma After Radiation Therapy Using Exquisite Systemic Therapy Histologically proven mesothelioma 16 Previously untreated mesothelioma 17 STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx3340https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{A614246A-90E8-4D83-B034-A9F5A647AF1A}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
6018695488959/9/2024 9:45:49 AM9/9/2024 9:45:49 AMA Phase 1 Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors Pancreatic Cancer - Mesothelioma - A pre-treatment biopsy or STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx2610https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{3E857B23-A933-4843-88B2-D14A314CA839}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
6019161186519/9/2024 9:38:09 AM9/9/2024 9:38:09 AMAn Open-label, Multicenter, Dose Escalation Phase 1b Study to Assess the Safety and MTC), gastroesophageal cancer (GEC), mesothelioma, breast cancer (BC) and ovarian STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx8110https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{E5E39B7D-F663-406C-8667-A63A1EF8C899}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
6018756267109/9/2024 9:45:39 AM9/9/2024 9:45:39 AMA Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With carcinoma, MSI-H CRC, esophagogastric cancer, mesothelioma, and HNSCC, all naïve to STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx3110https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{8E065694-8D88-4568-A874-E71AA1C68B7D}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
6016646335249/9/2024 9:32:53 AM9/9/2024 9:32:53 AMA Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab for Participants With Advanced Solid Tumors STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx2630https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{B871C8A9-618E-4F05-A3EE-BFB649E66A62}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
6016104704519/9/2024 9:30:55 AM9/9/2024 9:30:55 AMA Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects Cell Lung Carcinoma - Mesothelioma - Thyroid Carcinoma - Salivary Gland STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx3210https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{77B66B7F-ECE0-44EA-8CA9-38B3299B558E}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242

~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js

Last reviewed:
Last modified: 6/15/2021 11:04 AM
Back to Top